Matthew Austin, MD
Neuroradiology · Richmond, VANPI 1447463658
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $273,072 of the $279,049 with a category attached, or 97.9%. Stryker accounts for 98.0% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $274,404, more than ten times the $1,313 reported in 2019.
Across 154 payments — averaging $1812.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$273K
- Imperative Care, Inc$2K
- Medtronic$994
- Microvention, Inc.$959
- Balt USA, LLC$489
- Penumbra, Inc.$406
- plus $502 from 11 others
What the payments were for
- Royalty or licence$273,07298%
- Travel & lodging$6010%
- Food & beverage$5,3762%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 11 | $273,412 |
| Imperative Care, Inc | 54 | $2,287 |
| Medtronic(2 entities) | 37 | $994 |
| Microvention, Inc. | 9 | $959 |
| Balt USA, LLC | 7 | $489 |
| Penumbra, Inc. | 16 | $406 |
| Neurelis, Inc. | 1 | $82 |
| Angiodynamics, Inc. | 3 | $69 |
| Route 92 Medical, Inc. | 1 | $56 |
| Johnson & Johnson | 2 | $56 |
| UCB, Inc. | 2 | $52 |
| Boston Scientific | 3 | $51 |
| SK Life Science, Inc. | 2 | $35 |
| Phenox Inc. | 1 | $33 |
| Terumo Medical Corporation | 2 | $27 |
| AstraZeneca | 2 | $24 |
| Abbott | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few neuroradiology providers in Virginiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 26 | $265 |
Paid to pharmacies, not to this prescriber.
Other neuroradiology in Richmond
- Alejandro Santillan CadenillasRichmond$6K
- Afshan AhmadRichmond$588
- Adam GrayRichmond$220
- Robert BeskinRichmond$57
- Turner LewisRichmond$26
- Suraj KabadiRichmond$20
- Suehyb AlkhatibNorth Chesterfield$8K
- Milad YazdaniFalls Church$2K
- Joseph GorodenkerArlington$913
- James McEachernFalls Church$510
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.